Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) Phenylglycine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118028274A details a novel acylase mutant enhancing (S)-o-chlorophenylglycine synthesis. This breakthrough offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel BsLDH mutant enables efficient chiral amino acid synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN114507650B reveals a mutant enzyme boosting yield and purity for Clopidogrel intermediates, ensuring stable supply chains and reduced manufacturing costs for global buyers.
Patent CN114507650A details a high-efficiency biocatalytic route for Clopidogrel intermediates, offering superior stereoselectivity and substrate tolerance for scalable API manufacturing.
Advanced enzymatic synthesis patent analysis for high-purity Clopidogrel intermediates. Delivers cost reduction and supply chain reliability for pharmaceutical manufacturing.